Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome
Oct 15, 2026, 15:03

Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome

Mohamed Magdy, Physician at Ministry of Health Oman, shared a post on LinkedIn:

“Banti Syndrome

Banti syndrome is a condition characterized by splenomegaly (enlarged spleen) associated with portal hypertension and hypersplenism, leading to excessive destruction of blood cells.

Pathophysiology: Portal hypertension – Congestion of blood in the spleen – Splenomegaly (enlarged spleen) – Hypersplenism

Increased destruction/sequestration of blood cells:

  • Red blood cells – Anemia
  • White blood cells – Leukopenia
  • Platelets – Thrombocytopenia

Causes:

  • Liver cirrhosis
  • Portal vein obstruction/thrombosis
  • Other disorders affecting portal blood flow

Clinical Features:

  • Massive splenomegaly
  • Fatigue and pallor (due to anemia)
  • Increased infections (due to leukopenia)
  • Bleeding tendency or bruising (due to thrombocytopenia)
  • Features of portal hypertension (e.g., varices)

Key Exam Point: Banti syndrome equals to Portal hypertension plus Splenomegaly plus Hypersplenism

A patient with an enlarged spleen and pancytopenia (low RBCs, WBCs, and platelets) should raise suspicion for Banti syndrome/hypersplenism.”

Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome

Stau updated with Hemostasis Today.